Infliximab 5 mg/kg

DRUG4 trials

Sponsors

Janssen Research & Development, LLC, Centocor, Inc., Merck Sharp & Dohme LLC

Conditions

Crohn DiseaseCrohn's DiseaseUlcerative Colitis

Phase 2

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

CompletedNCT00269854

Centocor, Inc.Crohn Disease

Start: 1995-06-30End: 1996-10-31Updated: 2014-11-04

Phase 3

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

CompletedNCT00269841

Centocor, Inc.Crohn Disease

Start: 1996-05-31End: 1998-02-28Updated: 2014-11-04

Phase 4

Treatment With Infliximab in a Medical Setting (Study P05587)

TerminatedNCT00752622

Merck Sharp & Dohme LLCCrohn's Disease

Start: 2008-11-30End: 2010-06-30Updated: 2017-04-13

Unknown Phase

A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients

CompletedNCT00207688

Janssen Research & Development, LLCUlcerative Colitis

Start: 2004-08-31End: 2015-09-09Updated: 2018-07-06